This grant from the National Institute of Allergy and Infectious Diseases aims to support research focusing on the genetic validation and functional characterization of variants causing inborn errors of immunity. By investigating the molecular, cellular, and immunological mechanisms underlying primary immunodeficiency diseases, this opportunity seeks to enhance diagnosis, prognosis, and the development of targeted therapies. Applications are welcomed until November 29, 2021.
Opportunity ID: 310595
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-078 |
| Funding Opportunity Title: | Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Nov 26, 2018 |
| Last Updated Date: | Nov 29, 2021 |
| Original Closing Date for Applications: | Jan 07, 2022 |
| Current Closing Date for Applications: | Nov 29, 2021 |
| Archive Date: | Dec 29, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Native American tribal organizations (other than Federally recognized tribal governments) County governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities Special district governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) State governments Small businesses Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. Understanding the genetic basis of primary immunodeficiency disorders is essential for their diagnosis, prognosis, and the development of precision therapeutics. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-078.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Expired as per NOT-AI-22-005 | Nov 29, 2021 | |
| Nov 26, 2018 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-078 |
| Funding Opportunity Title: | Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Nov 26, 2018 |
| Last Updated Date: | Nov 29, 2021 |
| Original Closing Date for Applications: | Jan 07, 2022 |
| Current Closing Date for Applications: | Nov 29, 2021 |
| Archive Date: | Dec 29, 2021 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | City or township governments Native American tribal organizations (other than Federally recognized tribal governments) County governments For profit organizations other than small businesses Public housing authorities/Indian housing authorities Special district governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) State governments Small businesses Independent school districts |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: |
The purpose of this Funding Opportunity Announcement (FOA) is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. Understanding the genetic basis of primary immunodeficiency disorders is essential for their diagnosis, prognosis, and the development of precision therapeutics. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-078.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-19-078 |
| Funding Opportunity Title: | Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy and Infectious Diseases Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 26, 2018 |
| Last Updated Date: | Nov 26, 2018 |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | Jan 07, 2022 |
| Archive Date: | Feb 12, 2022 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) For profit organizations other than small businesses Independent school districts Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education County governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Special district governments Native American tribal organizations (other than Federally recognized tribal governments) State governments Native American tribal governments (Federally recognized) |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to advance the experimental validation and functional characterization of genetic variants in coding or non-coding genomic regions that result in inborn errors of immunity/primary immunodeficiency diseases and to elucidate the molecular, cellular, and immunological mechanisms of these disorders. Understanding the genetic basis of primary immunodeficiency disorders is essential for their diagnosis, prognosis, and the development of precision therapeutics. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAR-19-078.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-E | Use for due dates on or before May 24, 2020 | PKG00246462 | Jan 04, 2019 | May 24, 2020 | View | |
| FORMS-F | Use for due dates on or before January 24, 2022 | PKG00259209 | Jan 04, 2019 | Nov 30, 2021 | View | |
| FORMS-G | Use for due dates on or after January 25, 2022 | PKG00269686 | Oct 28, 2021 | Nov 30, 2021 | View |
Package 1
Mandatory forms
310595 RR_SF424_2_0-2.0.pdf
310595 PHS398_CoverPageSupplement_4_0-4.0.pdf
310595 RR_OtherProjectInfo_1_4-1.4.pdf
310595 PerformanceSite_2_0-2.0.pdf
310595 RR_KeyPersonExpanded_2_0-2.0.pdf
310595 PHS398_ResearchPlan_4_0-4.0.pdf
Optional forms
310595 RR_Budget_1_4-1.4.pdf
310595 RR_SubawardBudget30_1_4-1.4.pdf
310595 PHS398_ModularBudget_1_2-1.2.pdf
310595 PHS_AssignmentRequestForm_2_0-2.0.pdf
Package 2
Mandatory forms
310595 RR_SF424_2_0-2.0.pdf
310595 PHS398_CoverPageSupplement_5_0-5.0.pdf
310595 RR_OtherProjectInfo_1_4-1.4.pdf
310595 PerformanceSite_2_0-2.0.pdf
310595 RR_KeyPersonExpanded_2_0-2.0.pdf
310595 PHS398_ResearchPlan_4_0-4.0.pdf
310595 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf
Optional forms
310595 RR_Budget_1_4-1.4.pdf
310595 RR_SubawardBudget30_1_4-1.4.pdf
310595 PHS398_ModularBudget_1_2-1.2.pdf
310595 PHS_AssignmentRequestForm_3_0-3.0.pdf
Package 3
Mandatory forms
310595 RR_SF424_5_0-5.0.pdf
310595 PHS398_CoverPageSupplement_5_0-5.0.pdf
310595 RR_OtherProjectInfo_1_4-1.4.pdf
310595 PerformanceSite_4_0-4.0.pdf
310595 RR_KeyPersonExpanded_4_0-4.0.pdf
310595 PHS398_ResearchPlan_4_0-4.0.pdf
310595 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
310595 RR_Budget_3_0-3.0.pdf
310595 RR_SubawardBudget30_3_0-3.0.pdf
310595 PHS398_ModularBudget_1_2-1.2.pdf
310595 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
